Scientific Publications
Filter:
ForeseeHome
September 2001
Aging effects on vernier hyperacuity: A function of oscillation rate but not target contrast
Kline DW, Culham JC, Bartel P, Lynk L. Aging effects on vernier hyperacuity: a function of oscillation rate but not target contrast. Optom Vis Sci. 2001 Sep;78(9):676-82.
FDA Intended Use
ForeseeHome has not been approved by FDA for use other than described in the following Indication for Use: The ForeseeHome is intended for use in the detection and characterization of central and paracentral metamorphopsia (visual distortion) in patients with age-related macular degeneration as an aid in monitoring progression of disease factors causing metamorphopsia including, but not limited to choroidal neovascularization (CNV). It is intended to be used at home for patients with stable fixation.
Media enquiries? Reach out to our Media Contact
